Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous

Archives of Ophthalmology

Volumn 123, Issue 1, 2005, Pages 39-44

  Hariprasad, Seenu M ^a   Blinder, Kevin J ^a   Shah, Gaurav K ^a,d   Apte, Rajendra S ^a   Rosenblatt, Brett ^a   Holekamp, Nancy M ^a   Thomas, Matthew A ^a   Mieler, William F ^b   Chi, Jingduan ^c   Prince, Randall A ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

^d BARNES RETINA INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; EYE DROPS; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BACILLUS CEREUS; CHEMICAL STRUCTURE; CLINICAL ARTICLE; DRUG DOSE REGIMEN; DRUG PENETRATION; ENDOPHTHALMITIS; EYE INFECTION; HAEMOPHILUS INFLUENZAE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIAE; VITRECTOMY; VITREOUS BODY;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AQUEOUS HUMOR; AZA COMPOUNDS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; QUINOLINES; VITRECTOMY; VITREOUS BODY;

EID: 19944426971     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.123.1.39     Document Type: Article

References (17)

1. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122:1-17.
2. Affeldt JC, Flynn HW Jr, Forster RK, et al. Microbial endophthalmitis resulting from ocular trauma. Ophthalmology. 1987;94:407-413.
3. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology. 2002;109:13-24.
4. Bauernfeind A. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin, and ciprofloxacin. J Antimicrob Chemother. 1997;40:639-651.
5. Osato MS, Jenson HG, Trousdale MD, et al. The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates. Am J Ophthalmol. 1989;108:380-386.
6. Mather R, Karanchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol. 2002;133:463-466.
7. Kowalski RP, Dhaliwal DK, Karenchak LM, et al. Gatifloxacin and mexifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol. 2003;136:500-505.
8. Yamada M, Mochizuki H, Yamada K, et al. Aqueous humor levels of topically applied levofloxacin in human eyes. Curr Eye Res. 2002;24:403-406.
9. Cekic O, Batman C, Yasar U, et al. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration. Retina. 1998;18:521-525.
10. Cekic O, Batman C, Yasar U, et al. Human aqueous and vitreous humor levels of ciprofloxacin following oral and topical administration. Eye. 1999;13:555-558.
11. Stass H, Dalhoff A. Determination of BAY 12-8039, a new 8-methoxyquinolone. in human body fluids by high-performance liquid chromatography with fluorescence detection using on-column focusing. J Chromatogr B Biomed Sci Appl. 1997;702:163-174.
12. Clark WL, Kaiser PK, Flynn HW Jr, et al. Treatment strategies and visual acuity outcomes in chronic postoperative Propionibacterium acnes endophthalmitis. Ophthalmology. 1999;106:1665-1670.
13. Martin DF, Ficker LA, Aguilar HA, et al. Vitreous cefazolin levels after intravenous injection: effects of inflammation, repeated antibiotic doses, and surgery. Arch Ophthalmol. 1990;108:411-414.
14. Alfaro DV, Hudson SJ, Rafanan MM, et al. The effect of trauma on the ocular penetration of intravenous ciprofloxacin. Am J Ophthalmol. 1996;122:678-683.
15. Garcia-Saenz MC, Arias-Puente A, Fresnadillo-Martinez MJ, Carrasco-Font C. Human aqueous humor levels of oral ciprofloxacin, levofloxacin, and moxifloxacin. J Cataract Refract Surg. 2001;27:1969-1974.
16. Hariprasad SM, Mieler WF, Holz ER. Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch Ophthalmol. 2003;121:345-350.
17. Song A, Scott IU, Flynn HW Jr, Budenz DL. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology. 2002;109:985-991.